NATH BIOGENES (INDIA)
|
|
BOM : 537291     NSE : NATHBIOGEN     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Sep 26,2023 |
Price(EOD): βΉ 207.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Agriculture |
MCap: βΉ 394.06 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
NATH BIOGENES (INDIA) | -3.3% | -2.4% | 16.5% |
BOMBAY BURMAH TRADING CORPORATION | 2.6% | 21.3% | 24.7% |
KAVERI SEED COMPANY | -0.1% | 13.2% | 40.3% |
VENKYS (INDIA) | -1% | 2.8% | -6.7% |
BOMBAY SUPER HYBRID SEEDS | 4.8% | 2.2% | 204.5% |
MANGALAM GLOBAL ENTERPRISE | -5.7% | -28.4% | -66.7% |
TIERRA AGROTECH | -9.9% | -15.9% | -11.1% |
HARRISONS MALAYALAM | -4.4% | 13.7% | -3.3% |
JK AGRI GENETICS | -0.5% | -3.9% | -11.4% |
FUNDAMENTAL ANALYSIS OF NATH BIOGENES (INDIA)
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF NATH BIOGENES (INDIA)
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
10.42
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 37.81 Cr
[Latest Qtr - Jun2023 - Standalone Results ] 0.69
P/B Calculated based on Book Value of Rs 573.35 Cr
[Latest Year - Mar2023 - Standalone Results ] 1.2
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2023 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
78% 41% -16% |
SHARE PRICE MOMENTUM OF NATH BIOGENES (INDIA)
NATH BIOGENES (INDIA) vs SENSEX
DEBT OF NATH BIOGENES (INDIA)
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.17 0.16 0.13 0.15 |
- - - - |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF NATH BIOGENES (INDIA)
Pledged Promoter Shares |
16.38 % | |
---|---|---|
As on : Jun2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF NATH BIOGENES (INDIA)
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
423.84% 807.38% 1745.33% 1998.12% |
12.39% 7.52% 8.73% 8.6% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2023 | ||
Quarterly Result Analysis → |
NATH BIOGENES (INDIA) related INDICES
You may also like the below Video Courses
FAQ about NATH BIOGENES (INDIA)
Is NATH BIOGENES (INDIA) good for long term investment?
As on Sep 26,2023, the Fundamentals of NATH BIOGENES (INDIA) look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NATH BIOGENES (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is NATH BIOGENES (INDIA) UnderValued or OverValued?
As on Sep 26,2023, NATH BIOGENES (INDIA) is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of NATH BIOGENES (INDIA) ?
As on Sep 26,2023, the Intrinsic Value of NATH BIOGENES (INDIA) is Rs. 147.60 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 116.54
Fair Value [Median EV / Sales Model] : Rs. 147.60
Fair Value [Median Price / Sales Model] : Rs. 246.09
Estimated Median Fair Value of NATH BIOGENES (INDIA) : Rs. 147.60
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is NATH BIOGENES (INDIA) trading at a Premium or Discount?
As on Sep 26,2023, NATH BIOGENES (INDIA) is trading at a Premium of 41% based on the estimates of Median Intrinsic Value!BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
